First-Imaging Medical secures over RMB 100M in Series B+ to advance AI integration, charting the path for smart surgery

Recently, First-Imaging Medical, a leading enterprise in digital surgery solutions, announced the completion of its Series B+ round of financing, exceeding one hundred million RMB. The investors include Sichuan Development Hongke Fund, SBCVC, Great Stone Capital, Nantong Investment Management, and Zhongqi Group. The proceeds from this round will be primarily utilized for the market promotion of intelligent intraoperative imaging equipment and the research and development of digital consumables.

Since its inception, First-Imaging Medical has accurately identified industry development trends. Breaking through the limitation of traditional imaging equipment being confined to the radiology department, First-Imaging Medical focuses on the digitalization of surgical technology. By leveraging intraoperative 3D imaging technology innovation as a breakthrough, it supports the development of digital and intelligent surgical techniques. First-Imaging Medical continuously builds a closed-loop solution of "Equipment + AI + Ecosystem", thereby facilitating the leapfrog upgrade of surgical procedures from "experience-driven" to "intelligence-driven".

The field of digital surgery is entering a new wave of rapid development, with intraoperative imaging equipment serving as the core entry point for digital diagnosis and treatment. According to public data on C-arm winning bids across China in 2025 (based on data released by Zhao Cai Tong in January 2026), the total number of awarded units for the year reached 2,061, a year-on-year increase of approximately 37.3% compared to 1,501 units in 2024, indicating a significant surge in demand. The total value of awarded bids increased from RMB 2.04 billion to RMB 2.60 billion, a year-on-year increase of 27.5%. The average winning bid price was approximately RMB 1.26 million per unit, a decrease of 7.4% from RMB 1.36 million per unit in 2024, reflecting a price decline. 

However, from a product structure perspective, the 3D C-arm sector is experiencing a sudden rise. According to the latest bidding data released by Bidizhaobiao.com in 2025, the total number of 3D C-arm bids reached 207 units, achieving rapid year-on-year growth of 113%. First-Imaging Medical led the market by a significant margin with 74 awarded units, capturing a 35.7% market share. Its performance in terms of value was equally impressive, securing the top position in the industry with a 30.1% share. By achieving the number one market share in the 3D C-arm field for two consecutive years, First-Imaging Medical has solidly established its benchmark position among domestic Chinese intraoperative imaging equipment manufacturers.

Dr. Xi Yan, founder of First-Imaging Medical, is a leading expert in the interdisciplinary field of artificial intelligence and medical imaging, possessing profound academic knowledge and extensive industry practical experience. Today, digitalization and intelligence are reshaping the boundaries of surgery at an unprecedented pace. Intraoperative 3D imaging provides surgeons with a real-time, precise "smart eye," serving as the key to unlocking the door to the future of surgery.

After eight years of dedicated efforts, Dr. Xi Yan has led his team to successfully develop and launch five major product series, establishing a comprehensive matrix that covers the digital workflow of "pre-operative, intra-operative, and post-operative" phases, empowering clinical diagnosis and treatment. By breaking the historically high cost of intraoperative 3D imaging and achieving core technology self-reliance along with optimized and upgraded production processes, First-Imaging Medical's intraoperative 3D imaging products have served over 200 clinical hospitals and departments. This enables patients at the grassroots level to access millimeter-level precision treatment, ensuring that advanced medical care is no longer a "privilege" for the few but becomes a "right" for every patient.

First-Imaging Medical has broken the traditional constraint of "high performance equals large size." Through a product design philosophy emphasizing lightweight and intelligent features, its solutions are flexibly adaptable to multi-department surgical scenarios. Breaking the conventional form of intraoperative 3D imaging, the Super O-series O-arm CT features a full-circle large-bore design that transcends spatial limitations. The O-arm CT has won the first prize in the "China Respiratory Diagnosis and Treatment Technology and Equipment Innovation Project" for two consecutive years. Its 5S fast scanning technology allows patients to hold their breath more comfortably under local anesthesia and shortens the apnea time under general anesthesia, making it safer and more secure. The patented self-shielding lead design effectively reduces radiation exposure. By creating a fast and safe respiratory interventional diagnosis and treatment solution, First-Imaging Medical ensures that every surgery and every exposure is safeguarded by its commitment to security.

If intraoperative 3D imaging equipment is the ticket to smart surgery, then "3D Imaging +" is the ultimate foundation defining the future of precision medicine. It breaks through the functional boundaries of a single device, shifting from "point-based breakthroughs" to "systematic upgrades," thereby constructing a fully integrated, end-to-end digital surgery solution.

The FirstGUIDE cross-modal guidance function leverages First-Imaging Medical's high-definition 3D imaging technology to create a dedicated AI surgical plan. It achieves precise AI-driven multimodal image fusion and efficient registration during surgery, enabling rapid 2D-3D cross-modal guidance within five seconds. By deeply integrating specialized surgical tools with intelligent automatic recognition technology, it accurately predicts the needle guide path in real-time and completes dynamic planning, assisting surgeons in making proactive operational adjustments in advance. This truly realizes a closed-loop workflow of precise pre-operative planning and accurate intra-operative execution, comprehensively enhancing clinicians' diagnostic and treatment efficiency and enabling personalized precision treatment for patients.

The AF enhanced fluoroscopy function solves the "last one centimeter" challenge in respiratory intervention. Traditional 2D fluoroscopy fails to clearly visualize small nodules, causing bronchoscopy navigation to lose its path and become ineffective at the final stage, forcing clinicians to rely on experience to locate the lesion. The AF enhanced fluoroscopy function utilizes 3D image fusion technology combined with intelligent AI algorithms to enhance the display of ground-glass nodules in fluoroscopic images in the form of 3D virtual lesions. This guides clinicians to precisely locate the lesion and perform the surgery efficiently and quickly.

First-Imaging Medical's "3D Imaging +" strategy drives a critical upgrade of intraoperative 3D imaging technology from a surgical assistance tool to the core driver of decision-making. The intelligent surgical solutions built upon this strategy can significantly reduce the reliance of surgical procedures on physicians' clinical experience, effectively shorten the learning curve and career growth cycle for young doctors, and assist grassroots medical institutions in successfully performing high-precision surgeries. This tangibly promotes the decentralization of high-quality medical resources to the grassroots level, transforming the innovative achievements of smart medicine into accessible and universally beneficial value.